Kursprognose für Arrowhead Pharmaceuticals, Inc. (ARWR)ARWRArrowhead Pharmaceuticals, Inc.

Alphio's ARWR stock price prediction model matches the current Arrowhead Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $57.81 (-0.36%). The 1-week path is $58.04 (+0.04%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Arrowhead Pharmaceuticals Inc (ARWR) is currently not a strong buy due to its technical indicators and recent performance, despite promising clinical trial results. The current price is $58.02, with an RSI of 38.19 indicating it is nearing oversold territory. The forward P/E ratio is notably high at 111.11, suggesting that the stock may be overvalued at this time. The stock has seen a year-to-date change of -14.41%, which reflects ongoing volatility. However, the positive sentiment from analysts, particularly from Citi with a target of $108, suggests potential upside if clinical trials continue to yield favorable results. The main risk is the high forward P/E ratio, which indicates that the market may have high expectations that could lead to disappointment if future earnings do not meet these expectations.

Arrowhead Pharmaceuticals, Inc. (ARWR) last closed at $58.02, losing -0.58%. These facts feed the 1-day and 1-week ARWR price prediction above.